Ongoing treatment(s)-Chemotherapy - Page 10 of 12 Posts on Medivizor
Navigation Menu

Ongoing treatment(s)-Chemotherapy Posts on Medivizor

Radiation to the lymph nodes in stage II and II breast cancer; is it necessary?

Radiation to the lymph nodes in stage II and II breast cancer; is it necessary?

Posted by on Jun 11, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the effectiveness of radiotherapy treatment (uses high-energy radiation to kill cancer cells by damaging their DNA) on women with breast cancer who have previously had surgery. Some background Breast- conserving surgery (removes the breast cancer but not the breast itself) is just one method of breast...

Read More

Chemotherapy before surgery; is there a different in outcome between different types of breast cancer?

Chemotherapy before surgery; is there a different in outcome between different types of breast cancer?

Posted by on May 14, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to evaluate if the outcomes of surgery following chemotherapy are different based on the focality of breast cancer tumors.  Some background Breast cancer can be characterised as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found...

Read More

The effects of chemotherapy on thyroid function

Posted by on May 12, 2015 in Breast cancer | 2 comments

In a nutshell The authors aimed to assess whether chemotherapy has an impact on thyroid function.  Some background The thyroid is an endocrine gland (tissue that releases hormones) found in the neck. It controls how quickly the body uses energy used in the body, how the body reacts to other hormones and makes proteins. Thyroid hormones can...

Read More

Can we estimate the benefit of vandetanib and docetaxel in advanced non-small cell lung cancer?

Can we estimate the benefit of vandetanib and  docetaxel in advanced non-small cell lung cancer?

Posted by on May 12, 2015 in Lung cancer | 0 comments

In a nutshell The aim of this study was to determine whether the benefit from combination therapy of vandetanib (Caprelsa) and docetaxel (Taxotere) could be linked to specific biological substances in non-small cell lung cancer (NSCLC) patients. Some background In advanced stage (IIB/IV) NSCLC, cancer may spread throughout lungs and to other...

Read More

Benefits of personalized dosing of 5-fluorouracil: decreased side effects and improved outcomes

Benefits of personalized dosing of 5-fluorouracil: decreased side effects and improved outcomes

Posted by on Jan 12, 2015 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the benefits of personalized 5-fluorouracil (Efudex) dosing in early and late-stage colorectal cancer patients. Some background 5-fluorouracil has been a mainstay of colorectal cancer chemotherapy for over 50 years. Research has shown that in order for 5-fluorouracil to work effectively target concentrations need...

Read More

Chemoradiotherapy reduces physical fitness in rectal cancer patients waiting for surgery

Chemoradiotherapy reduces physical fitness in rectal cancer patients waiting for surgery

Posted by on Dec 15, 2014 in Colorectal cancer | 0 comments

In a nutshell This small study investigated the effect of neoadjuvant chemoradiotherapy on whole-body physical fitness. Some background Locally advanced rectal cancer indicates that the cancer has spread beyond the lining of the rectum or has spread to the nearby lymph nodes. Patients with locally advanced rectal cancer routinely receive...

Read More

Blood protein levels could predict benefit of gefitinib in patients with advanced disease

Blood protein levels could predict benefit of gefitinib in patients with advanced disease

Posted by on Dec 5, 2014 in Lung cancer | 0 comments

In a nutshell This study investigated using levels of the proteins MUC1 and VEGF to predict the benefit of gefitinib in patients with advanced NSCLC. Some background Non small-cell lung cancer (NSCLC) is a common type of lung cancer that can be difficult to treat. 65-75% of cases are presented at an advanced stage. Chemotherapy is often...

Read More

Detecting chemoresistance before treatment

Detecting chemoresistance before treatment

Posted by on Oct 17, 2014 in Lung cancer | 0 comments

In a nutshell This analysis explored whether class 3 β-tubulin levels are associated with chemoresistance in non-small cell lung cancer. Some background Non-small cell lung cancer often has no symptoms in the early stages, and therefore is often diagnosed at later stages. Despite treatment advances, the outlook for later-stage non-small cell...

Read More

Can more radiation help?

Can more radiation help?

Posted by on Oct 6, 2014 in Lung cancer | 0 comments

In a nutshell This study focused on the effectiveness of thoracic radiotherapy in treating extensive stage small-cell lung cancer. Some background Small-cell lung cancer (SCLC) is a fast growing cancer that has a tendency to spread to other parts of the body like the brain, liver and bone. Often, SCLC has already spread to the brain even if...

Read More